BioSpace News Archive

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018

As of January 31, 2018, shares and voting rights outstanding of Essilor, the world leader in ophthalmic optics, broke down as follows:

February 7, 2018

·

1 min read

TiGenix: Transparency Information - Feb. 7, 2018

Following the issuance of 413,283 new shares on February 6, 2018 resulting from the exercise of 413,283 warrants of TiGenix NV, the transparency data have changed as follows (status on February 6, 2018):

February 7, 2018

·

3 min read

Business

Medicen Paris Region: French Society of Radiology Becomes the First ‘Learned Society’ to Join the Cluster

Medicen Paris Region, the leading health cluster in Europe, today announces that the French Society of Radiology (SFR) joined the cluster as the first ‘learned society’ member.

February 7, 2018

·

4 min read

Business

InfuSystem Holdings Reports Interim CFO Will Leave Company at End of Current Quarter

Mr. Downs resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company’s financial performance.

February 7, 2018

·

4 min read

Business

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017

Enanta’s cash, cash equivalents and short-term and long-term marketable securities totaled $297.5 million at December 31, 2017.

February 7, 2018

·

11 min read

Business

ViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors

The Company also announced the impending resignations of two directors: David Bonita, M.D., and Mark S. Gold, M.D. Both Dr. Bonita and Dr. Gold announced their intention to step down from the Board at the Company’s Annual Meeting.

February 7, 2018

·

4 min read

Business

Taro Provides Results for December 31, 2017

Cash flow provided by operations for the nine months ended December 31, 2017, was $225.8 million compared to $320.5 million for the nine months ended December 31, 2016.

February 7, 2018

·

12 min read

Business

Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018

Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions.

February 7, 2018

·

2 min read

Biotech Beach

Evolus Announces Pricing of Initial Public Offering of Common Stock

Evolus has also granted the underwriters a 30-day option to purchase an additional 750,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

February 7, 2018

·

3 min read